cell

(redirected from ES cell)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.
Related to ES cell: SCNT

cell

an independent team of operatives who work together in a CELLULAR MANUFACTURING production environment.
References in periodicals archive ?
The self-renewal and differentiation of murine ES cells is Regulated by several signaling pathways.
He was instrumental in the first targeting of a mouse chromosomal gene (HPRT) in ES cells and its germline transmission and went on to be pivotal in the creation of numbers of targeted mouse mutations including proto-oncogenes and tumoursupressor genes.
At the core of the ES cell issue is the question: when does life begin?
Although ES cells are attractive in their pluripotency and availability of intact and stable undifferentiated status, there are difficulties in clinical applications of human ES cells because of safety and ethics.
iPS Cells--Starting cells Mouse Embryonic fibroblasts Adult tail fibroblasts Hcpatocytcs Gastric epithelial cell Pancreatic cell Neural stem cell Blymphocyte Keratinocyte Human Skin fibroblast Keratinocyte Bone marrow stem cell Peripheral blood cell Transcription factors for reprogramming Transcription factors are proteins that bind to DNA and regulate gene expression Oct3/4and Sox2: transcription factors that function in maintaining pluripotency in both early embryos and ES cells. c-Myc and Klf4: transcription factors that modify chromatin structure so that Oct3/4 and Sox2 can bind to their target; proto-oncogenes [ILLUSTRATION OMITTED] Proposed Mechanisms of Reprogramming.
Xcelthera proprietary PluriXcel technology allows efficient derivation of clinical-grade human ES cell lines and direct conversion of such pluripotent human ES cells by small molecule induction into a large commercial scale of high quality human neuronal or heart muscle cells, which constitutes clinically representative progress in both human neuronal and cardiac therapeutic products for treating neurodegenerative and heart diseases.
The characterization of the HFB-ES cell line developed during the present study revealed that it confirmed to the majority of attributes described for ES cell line.
Our findings reveal that ES cell differentiation induced by LIF-removal is associated with a 50% reduction in levels of hydroxymethylcytosine that is likely to be due to downregulation of TET genes.
To insure that we tracked only cells positive for a functional AHR, we established the pAHRPuroIRESeGFP cell line, a stable ES cell line that expresses the selection markers puromycin resistance and eGFP under control of the Cyp1a1 promoter, and therefore responds to TCDD treatment (see Supplemental Material, Figure S3A).
BioTime will own the stake directly and through its wholly-owned subsidiary ES Cell International Pte Ltd.
In consequence of the ethical difficulties of obtaining fertilised human eggs, numerous ES cell lines have been created.